Pancreatic Cancer Research

ResearcherShanghai Medical College of Fudan UniversityNo recent work listed

Qi Qi

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-4460-0713; OpenAlex author ID A5100406589. Sources: OpenAlex.

Their work

Papers
9 (first author 4, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
22
Papers, trials and grants by year

2012: 1 paper · 2013: none · 2014: 1 paper · 2015: 3 papers · 2016: 1 paper · 2017: 1 paper · 2018: 1 paper · 2019: none · 2020: 1 paper

Papers 9

  1. Serum level of CCL2 predicts outcome of patients with pancreatic cancer. First author PMID 32603049↗
  2. Serum levels of IL-6, IL-8, and IL-10 are indicators of prognosis in pancreatic cancer. First author DOI 10.1177/0300060518800588↗
  3. Serum lactate dehydrogenase predicts prognosis and correlates with systemic inflammatory response in patients with advanced pancreatic cancer after gemcitabine… Co-author DOI 10.1038/srep45194↗
  4. A novel systemic inflammation response index (SIRI) for predicting the survival of patients with pancreatic cancer after chemotherapy. Co-author DOI 10.1002/cncr.30057↗
  5. Prognostic nutritional index predicts survival and correlates with systemic inflammatory response in advanced pancreatic cancer. First author DOI 10.1016/j.ejso.2015.07.022↗
  6. Clinical implications of systemic inflammatory response markers as independent prognostic factors for advanced pancreatic cancer. Co-author DOI 10.1016/j.pan.2014.12.004↗
  7. Hyperfibrinogen Is Associated With the Systemic Inflammatory Response and Predicts Poor Prognosis in Advanced Pancreatic Cancer. Co-author DOI 10.1097/mpa.0000000000000353↗
  8. Chinese herbal medicine suppresses invasion-promoting capacity of cancer-associated fibroblasts in pancreatic cancer. Co-author DOI 10.1371/journal.pone.0096177↗
  9. Oridonin nanosuspension was more effective than free oridonin on G2/M cell cycle arrest and apoptosis in the human pancreatic cancer PANC-1 cell line. First author DOI 10.2147/ijn.s29483↗

Closest collaborators

The 22 strongest of 22 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Zhen Chen · 8 shared papers, 2014–2020 · strength 0.57
  2. Yawen Geng · 5 shared papers, 2015–2017 · strength 0.31
  3. Zhiqiang Meng · 4 shared papers, 2014–2020 · strength 0.31
  4. Lanyun Feng · 2 shared papers, 2018–2020 · strength 0.22
  5. Peng Wang · 3 shared papers, 2014–2018 · strength 0.20
  6. Hao Chen · 3 shared papers, 2014–2016 · strength 0.16
  7. Luming Liu · 2 shared papers, 2014–2018 · strength 0.13
  8. P Wang · 1 shared paper, 2020 · strength 0.13
  9. Lu-Ming Liu · 1 shared paper, 2020 · strength 0.13
  10. P. Wang · 2 shared papers, 2015 · strength 0.12
  11. Shu-Lin Yu · 1 shared paper, 2017 · strength 0.07
  12. Hao Chen · 1 shared paper, 2017 · strength 0.07
  13. Shulin Yu · 1 shared paper, 2016 · strength 0.06
  14. Yehua Shen · 1 shared paper, 2016 · strength 0.06
  15. Peng Wang · 1 shared paper, 2016 · strength 0.06
  16. Liping Zhuang · 1 shared paper, 2016 · strength 0.06
  17. Luming Liu · 1 shared paper, 2016 · strength 0.06
  18. Chao Qu · 1 shared paper, 2014 · strength 0.04
  19. Kun Wang · 1 shared paper, 2014 · strength 0.04
  20. Lianyu Chen · 1 shared paper, 2014 · strength 0.04
  21. Keli Tian · 1 shared paper, 2012 · strength 0.03
  22. Zhang · 1 shared paper, 2012 · strength 0.03

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.